By: Kairos Ventures On: July 29, 2022 In: Kairos News

Jim Demetriades speaks with MoochFM host Anthony Scaramucci to discuss investing in science and its ability to change the...

Read more

Seed Health and Axial Therapeutics announced a joint development program targeting the microbiome-gut-brain axis for mental health, with the potential...

Read more

Behavioral Signals, a Los Angeles-based software company and provider in Conversational AI technology, announces its partnership with ddCom Systems,...

Read more
By: Kairos Ventures On: July 7, 2022 In: MemVerge, Portfolio News

MemVerge Memory Machine™ has achieved Red Hat OpenShift Operator and container certifications. This is an important step in enabling...

Read more
By: Kairos Ventures On: June 22, 2022 In: Portfolio News, Provivi

Provivi will participate in the World Agri-Tech South America Summit as a Gold Partner, taking place virtually and in...

Read more
By: Kairos Ventures On: June 13, 2022 In: Kairos III, Kairos News

Kairos Ventures, which bankrolls university scientists and invests in startups emerging from their research, said it has raised $58...

Read more

Transient Plasma Systems (TPS) has invented a new plasma-based ignition system that can improve fuel combustion efficiency by as...

Read more
By: Kairos Ventures On: June 6, 2022 In: Portfolio News, Provivi

Provivi was awarded the 2022 Green Chemistry Challenge Award in the Small Business Category. The EPA has been running...

Read more
By: Kairos Ventures On: June 6, 2022 In: Neuro-Bio, Portfolio News

Neuro-Bio is ready to move to human trials using a radical approach that targets neurodegeneration long before it can...

Read more
By: Kairos Ventures On: June 6, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc. announced the presentation of clinical data from its phase 1/2 clinical trial of LNS8801 in combination...

Read more